Sky Century Investment (SKYI) Cost of Revenue (2024 - 2026)
Sky Century Investment (SKYI) posted quarterly Cost of Revenue of $12297.0 for Q2 2026, down 1.01% year-over-year from $12423.0 in Q2 2025, and up 5.46% quarter-over-quarter from $11660.0 in Q1 2026.
Sky Century Investment (SKYI) Cost of Revenue (2024 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has reported Cost of Revenue for 3 consecutive years, with $12297.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Cost of Revenue fell 1.01% year-over-year to $12297.0; the TTM figure through May 2026 stood at $59426.0 (up 34.14% YoY), while the FY2025 annual figure was $51859.0, up 49.57% from the prior year.
- Cost of Revenue advanced to $12297.0 in Q2 2026 per SKYI's latest filing, from $11660.0 in the prior quarter.
- Across five years, Cost of Revenue topped out at $18459.0 in Q4 2025 and bottomed at $8406.0 in Q1 2024.
- Historically, Cost of Revenue has averaged $12054.0 across 3 years, with a median of $11652.5 in 2025.
- Annual changes were most pronounced in 2025 — Cost of Revenue soared 79.94% — and 2026, when it retreated 1.01%.
- Sky Century Investment's Cost of Revenue stood at $10781.0 in 2024, then surged by 71.22% to $18459.0 in 2025, then slumped by 33.38% to $12297.0 in 2026.
- Business Quant data shows SKYI's Cost of Revenue at $12297.0 in Q2 2026, $11660.0 in Q1 2026, and $18459.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Sky Century Investment | 393,547.71 | 393,283.71 | 26,045.00 | 12,297.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 12,297.00 |
| May 31, 2026 | 12,297.00 |
| Feb 28, 2026 | 11,660.00 |
| Feb 28, 2026 | 11,660.00 |
| Nov 30, 2025 | 18,459.00 |
| Nov 30, 2025 | 18,459.00 |
| Aug 31, 2025 | 17,010.00 |
| Aug 31, 2025 | 17,010.00 |
| May 31, 2025 | 12,423.00 |
| May 31, 2025 | 12,423.00 |
| Feb 28, 2025 | 11,645.00 |
| Feb 28, 2025 | 11,645.00 |
| Nov 30, 2024 | 10,781.00 |
| Nov 30, 2024 | 10,781.00 |
| Aug 31, 2024 | 9,453.00 |
| Aug 31, 2024 | 9,453.00 |
| May 31, 2024 | 8,406.00 |
| May 31, 2024 | 8,406.00 |
| Feb 29, 2024 | 8,406.00 |
| Feb 29, 2024 | 8,406.00 |